MedTrace Logo

Effect of EPAP Device on Emphysema and Lung Bullae

NCT04742114 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-03-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and the effects and of the application of Expiratory Positive Airway Pressure (EPAP) device on Dynamic Hyperinflation and dyspnea in patients with Emphysema and pulmonary bullae.

Conditions

  • Emphysema
  • Bullous Disease Lung

Interventions

DEVICE

use the face mask with Expiratory Positive Airway Pressure(EPAP).

The subjects were divided into two groups. The first group use the face mask without EPAP, and the other group use the face mask with EPAP.

DEVICE

use the face mask without Expiratory Positive Airway Pressure(EPAP).

The subjects were divided into two groups. The first group use the face mask without EPAP, and the other group use the face mask with EPAP.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Principal Investigators

  • dedong ma, Doctor · Qilu Hospital of Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-31
Primary Completion
2022-11-10
Completion
2022-11-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04742114 on ClinicalTrials.gov